# FDA recall D-1571-2014

> **Akorn, Inc.** · Class III · drug recall initiated 2014-08-05.

## Product

Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42

## Reason for recall

Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1571-2014
- **Recalling firm:** Akorn, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-08-05
- **Report date:** 2014-10-01
- **Termination date:** 2015-05-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1571-2014

## Citation

> AI Analytics. FDA recall D-1571-2014. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1571-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*